Bionime Stock

Bionime Net Margin

The Net Profit Margin of Bionime (4737.TW) as of Aug 16, 2026 is -9.81 %. In the previous year, Net Profit Margin was -6.58 % — a change of 49.04% (lower).

Net Margin

-9.81 %

YoY

49.04%

Last updated:

Net Profit Margin of Bionime is 2026 -9.81 % . Net Profit Margin of Bionime was 2025 -6.58 % . It decreases by 49.04% lower compared to the previous year.

Bionime's net margin stands at -9.8%, down from 4.7% several years earlier.

Access this data via the Eulerpool API

Bionime Stock analysis

What does Bionime do? Bionime Corp is a company that was founded in 2003 and specializes in the development and manufacture of medical devices for measuring blood sugar levels and other cardiovascular tests. Bionime is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bionime stock

Net Profit Margin of Bionime is -9.81 % in 2026.

Net Profit Margin of Bionime changed from -6.58 % to -9.81 %, representing a 49.04% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Bionime since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Bionime with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

Margins — Bionime

All Key Metrics — Bionime